{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:24Z","timestamp":1790352504122,"version":"4.1.0"},"reference-count":23,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Hosp Pharm"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Cryptosporidiosis is an infectious disease caused by the Cryptosporidium parasite, primarily affecting the gastrointestinal tract of both humans and animals. Transmission occurs via fecal-oral route, mainly through ingestion of water or food contaminated with oocysts, the parasite\u2019s infectious form. Immunocompromised individuals are particularly susceptible to severe and prolonged symptoms. Current treatment strategies involve supportive measures and antiparasitic medications such as nitazoxanide and paromomycin, although patients with predisposing factors have an elevated risk of recurrence. There is currently no evidence supporting the use of paromomycin via nasogastric tube. Therefore, we present our experience with the use of an extemporaneous paromomycin solution and its clinical impact.<\/jats:p>","DOI":"10.1177\/00185787241299621","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T03:09:38Z","timestamp":1732763378000},"page":"117-123","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Experience With the Use of Paromomycin Via Nasogastric Tube as Treatment for Cryptosporidium Infection: A Case Report"],"prefix":"10.1177","volume":"60","author":[{"given":"Iv\u00e1n","family":"Cores Rodr\u00edguez","sequence":"first","affiliation":[{"name":"Segovia Hospital Complex, Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8687-3691","authenticated-orcid":false,"given":"Eduardo","family":"Tejedor Tejada","sequence":"additional","affiliation":[{"name":"Segovia Hospital Complex, Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ortiz del Olmo","sequence":"additional","affiliation":[{"name":"Segovia Hospital Complex, Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bern\u00e1rdez Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Rio Hortega University Hospital, Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Criado Illana","sequence":"additional","affiliation":[{"name":"Segovia Hospital Complex, Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"Cryptosporidiosis. Center for disease control and prevention. 2024. Accessed August 22 2024. https:\/\/www.cdc.gov\/dpdx\/cryptosporidiosis\/index.html"},{"key":"e_1_3_2_3_2","unstructured":"Criptosporidiosis. Instituto de Salud Carlos III. 2022. Accessed August 22 2024. https:\/\/www.isciii.es\/QueHacemos\/Servicios\/VigilanciaSaludPublicaRENAVE\/EnfermedadesTransmisibles\/Documents\/archivos%20A-Z\/Criptosporidiosis\/Informe_Criptosporidium_2022.pdf"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2005.00134.x"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30283-3"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.2.419"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199703000-00004"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0037-86821998000400001"},{"issue":"6","key":"e_1_3_2_9_2","first-page":"1045","article-title":"Prevenci\u00f3n del s\u00edndrome de realimentaci\u00f3n [Prevention of the refeeding syndrome]","volume":"25","author":"Mart\u00ednez N\u00fa\u00f1ez ME","year":"2010","unstructured":"Mart\u00ednez N\u00fa\u00f1ez ME, Hern\u00e1ndez Muniesa B. Prevenci\u00f3n del s\u00edndrome de realimentaci\u00f3n [Prevention of the refeeding syndrome]. Nutr Hosp. 2010;25(6):1045-1048.","journal-title":"Nutr Hosp"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1258\/0956462971919543"},{"key":"e_1_3_2_11_2","unstructured":"Leder K Weller P. Cryptosporidiosis: treatment and prevention. UpTodate. Bogorodskay M. Ryan T. 2024. Accesed August 2024. https:\/\/www.uptodate.com\/contents\/cryptosporidiosis-treatment-and-prevention"},{"key":"e_1_3_2_12_2","volume-title":"Gu\u00eda Terap\u00e9utica Antimicrobiana","author":"Mensa J","year":"2024","unstructured":"Mensa J, Soriano A, L\u00f3pez-Su\u00f1e E, Llinares P, Zboromysrka Y, Barber\u00e1n J. Gu\u00eda Terap\u00e9utica Antimicrobiana. Barcelona: Editorial Antares; 2024."},{"key":"e_1_3_2_13_2","unstructured":"PubChem. National Library of Medicine. Paromomycin [Internet]. 2024. Accesed August 2024. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Paromomycin"},{"key":"e_1_3_2_14_2","unstructured":"Casaus Lara ME Tarno Fern\u00e1ndez ML Mart\u00edn de Rosales Cabrera AM Garc\u00eda Salom P. Gu\u00eda de Buenas Pr\u00e1cticas de medicamentos en Servicios de Farmacia. Spanish Ministry of Health. [Internet]. 2024. Accessed October 2024. https:\/\/www.sanidad.gob.es\/areas\/farmacia\/publicaciones\/GuiaBPMedicamentosServFarmHosp\/Docs\/04GuiaMedicamentos2024Accesible.pdf"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.229"},{"key":"e_1_3_2_16_2","first-page":"165","volume-title":"Formulaci\u00f3n Magistral Oft\u00e1lmica Antiinfecciosa","author":"Diaz-Tom\u00e9 V","unstructured":"Diaz-Tom\u00e9 V, Alonso JM, Ferro I. Elaboraci\u00f3n de otros colirios antiinfecciosos. In: AF Ferreiro, ed. Formulaci\u00f3n Magistral Oft\u00e1lmica Antiinfecciosa. SEFH; 2019:165-166."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(96)01902-4"},{"key":"e_1_3_2_18_2","unstructured":"Spanish Agency for Medicines and Medicinal Products (AEMPS\u2014CIMA) [Internet]. Madrid:Humantin 250 mg capsules: data sheet; 28\/02. 2022. Accesed August 2024. https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/36795\/FT_36795.html"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-062917-011942"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/318155"},{"issue":"2","key":"e_1_3_2_21_2","first-page":"463","article-title":"Comparative study between the effect of nitazoxanide and paromomycine in treatment of cryptosporidiosis in hospitalized children","volume":"43","author":"Hussien SM","year":"2013","unstructured":"Hussien SM, Abdella OH, Abu-Hashim AH, et al. Comparative study between the effect of nitazoxanide and paromomycine in treatment of cryptosporidiosis in hospitalized children. J Egypt Soc Parasitol. 2013;43(2):463-470.","journal-title":"J Egypt Soc Parasitol"},{"key":"e_1_3_2_22_2","volume-title":"Gu\u00eda de Administraci\u00f3n de Medicamentos Por Sonda de Alimentaci\u00f3n Enteral","author":"Pe\u00f1a Pedrosa JA","year":"2012","unstructured":"Pe\u00f1a Pedrosa JA, Santiago P\u00e9rez A, Arenaza Pe\u00f1a AE, et al. Gu\u00eda de Administraci\u00f3n de Medicamentos Por Sonda de Alimentaci\u00f3n Enteral. Hospital Cl\u00ednico San Carlos. Madrid; 2012."},{"key":"e_1_3_2_23_2","first-page":"1","article-title":"Alternatives for the administration of oral antineoplastics in patients with swallowing difficulties","volume":"2024","author":"Tejedor Tejada E","unstructured":"Tejedor Tejada E, Gonzalez Su\u00e1rez S, Lizondo L\u00f3pez T, L\u00f3pez-Cabezas C, Soy Muner D. Alternatives for the administration of oral antineoplastics in patients with swallowing difficulties. J Chemother. 2024:1-14.","journal-title":"J Chemother"},{"key":"e_1_3_2_24_2","unstructured":"De Andr\u00e9s Morera S Alvarez Criado J Moreno Palomina M et al. Gu\u00eda para la administraci\u00f3n de medicamentos a pacientes con problemas de degluci\u00f3n; 2021."}],"container-title":["Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00185787241299621","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00185787241299621","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00185787241299621","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:04:36Z","timestamp":1784545476000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00185787241299621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1177\/00185787241299621"],"URL":"https:\/\/doi.org\/10.1177\/00185787241299621","relation":{},"ISSN":["0018-5787","1945-1253"],"issn-type":[{"value":"0018-5787","type":"print"},{"value":"1945-1253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]}}}